Autorizzazione alla conduzione dello Studio “Observational study to assess the efficacy and safety of bendamustine plus rituximab in patients affected by chronic lumphocytic leukemia” . Codice: LLC1315
Sei in questa pagina: | Home | / Eventi / DELIBERE 2016 /
Delibera n° 226
Autorizzazione alla conduzione dello Studio “Observational study to assess the efficacy and safety of bendamustine plus rituximab in patients affected by chronic lumphocytic leukemia” . Codice: LLC1315
|